Related Experiment Video
Updated: Aug 14, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Nanoparticles in melanoma
M A Berciano-Guerrero, A Montesa-Pino, G Castaneda-Penalvo
1Medical Oncology Section, Hospital Regional Universitario Carlos Haya, Malaga, Avda. Carlos Haya s/n; 29010 Malaga, Spain. migueberci@gmail.com.
Abstract:
Malignant melanoma is one of the most common causes of cancer and cancer deaths in young people. Until few years ago, scarce drugs have proven efficacy in metastatic setting. However, in the recent years, the treatment of metastatic malignant melanoma has undergone the incorporation of effective treatment such as immunotherapy, the use of tyrosine kinase inhibitors and the emergence of other cytostatic compounds, like the nanoparticles. This review aims to propose a standardization to classify the different types of nanoparticles, according to chemical aspects, and update the clinical research with nanoparticles and their use in melanoma field.
Insights
Nanoparticles offer new hope for treating metastatic malignant melanoma, a leading cause of cancer death in young adults. This review standardizes nanoparticle classification and updates research on their clinical use in melanoma treatment.
Area of Science:
- Oncology
- Nanotechnology
- Materials Science
Background:
- Malignant melanoma is a significant cause of cancer mortality, particularly in younger populations.
- Limited treatment options were available for metastatic melanoma until recently.
- Advances include immunotherapy, tyrosine kinase inhibitors, and nanoparticle-based therapies.
Purpose of the Study:
- To propose a standardized classification system for nanoparticles based on chemical properties.
- To provide an updated overview of clinical research involving nanoparticles in melanoma treatment.
Main Methods:
- Literature review of existing research on nanoparticle classification.
- Synthesis of current clinical trial data on nanoparticle applications in melanoma.
Main Results:
- Identified key chemical characteristics for nanoparticle categorization.
- Summarized the efficacy and safety profiles of various nanoparticles in melanoma treatment.
Conclusions:
- A standardized classification will aid in understanding and developing nanoparticle therapies.
- Nanoparticles represent a promising frontier in the management of metastatic malignant melanoma.
